Unique ID issued by UMIN | UMIN000030317 |
---|---|
Receipt number | R000034621 |
Scientific Title | Related examination of the serum gastrin level of patients with gastroesophageal reflux disease in the acid-secreting suppressant administration treatment and the intragastric acid kinetics of secretion |
Date of disclosure of the study information | 2017/12/08 |
Last modified on | 2017/12/08 16:26:56 |
Related examination of the serum gastrin level of patients with gastroesophageal reflux disease in the acid-secreting suppressant administration treatment and the intragastric acid kinetics of secretion
Related examination of the serum gastrin level of patients with gastroesophageal reflux disease in the acid-secreting suppressant administration treatment and the intragastric acid kinetics of secretion
Related examination of the serum gastrin level of patients with gastroesophageal reflux disease in the acid-secreting suppressant administration treatment and the intragastric acid kinetics of secretion
Related examination of the serum gastrin level of patients with gastroesophageal reflux disease in the acid-secreting suppressant administration treatment and the intragastric acid kinetics of secretion
Japan |
The acid-secreting suppressant-resistant GERD patients
Gastroenterology |
Others
NO
We examine the association of the ratio in patients with treated gastroesophageal reflux disease eight weeks or more with PPI and P-CAB standard dose at under intragastric pH 4 time for serum gastrin level and 24 hours.
Others
We perform 24pHMII for the purpose of gastroesophageal reflux dynamics associated with the onset of symptom of subjects and intragastric acid drying effect.
Others
Others
Not applicable
Serum gastrin level of the acid-secreting suppressant-resistant GERD patients
Observational
20 | years-old | <= |
Not applicable |
Male and Female
atients with GERD symptom survival that the patients who gastroesophageal reflux disease was diagnosed in this hospital, and received treatment eight weeks or more with PPI or P-CAB standard dose showed more than two points in GERDQ
The patients with a history of the following disease or the patients who merge now
Zollinger -Ellison syndrome ,Oesophageal stenosis ,Serious esophagus dyskinesia including the achalasia symptom ,Cerebrovascular disorder such as cerebral hemorrhage, cerebral infarction. The Helicobacter pylori infection history patients.
The patients who have difficulty in participation in this study by a merger with serious hepatic disorder, renal disease, heart disorder .A malignant lesion was confirmed; or is the patients with suspected malignant lesion. A pregnant woman, nursing mother or the woman who may be pregnant .In addition, the patients who judged that clinical studies responsibility physician or the study medical attendant was inadequate
500
1st name | |
Middle name | |
Last name | Funaki Yasushi |
Department of Intermal Medicine Aichi Medical University
Division of Gastroenterology
1-1Yazakokarimata,Nagakute,Aichi
0561-62-3311
momomaru@aichi-med-u.ac.jp
1st name | |
Middle name | |
Last name | Funaki Yasushi |
Department of Intermal Medicine Aichi Medical University
Division of Gastroenterology
1-1Yazakokarimata,Nagakute,Aichi
0561-62-3311
momomaru@aichi-med-u.ac.jp
Department of Intermal Medicine Aichi Medical University
Department of Intermal Medicine Aichi Medical University
Other
NO
愛知医科大学病院(愛知県)
2017 | Year | 12 | Month | 08 | Day |
Unpublished
Enrolling by invitation
2017 | Year | 11 | Month | 21 | Day |
2017 | Year | 12 | Month | 08 | Day |
non
2017 | Year | 12 | Month | 08 | Day |
2017 | Year | 12 | Month | 08 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034621